Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension
- PMID: 11054722
- DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH715>3.0.CO;2-Q
Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension
Abstract
The hypothesis for this study was that increased local expression of vascular angiotensin-converting enzyme (ACE) may contribute to the arterial remodelling which accompanies pulmonary hypertension, since angiotensin II (ANG II) is an important mediator of pulmonary vascular cell growth. The expression of ACE was studied by immunohistochemistry in paraffin-embedded lung sections from adults undergoing heart-lung transplantation for severe primary (n=6) and secondary (n=7) pulmonary arterial hypertension (PH), compared with age-matched controls (n=11). An antigen retrieval technique was used prior to incubating sections with the anti-ACE monoclonal antibody, CG2, or the endothelial marker, monoclonal anti-CD31. In control lungs, the highest level of ACE immunostaining was seen in the alveolar capillary endothelium, with less intense staining in small intra-acinar pulmonary arteries and relatively little staining in larger preacinar arteries. ACE immunostaining was virtually absent in lymphatics and veins. In both primary and secondary PH, there was an increase in ACE immunostaining in the endothelium of intra-acinar peripheral pulmonary arteries compared with control lungs, extending to the level of alveolar ducts, as confirmed by semi-quantitative analysis. The increase in endothelial ACE expression in the intra-acinar arteries of patients with primary and secondary PH is consistent with the hypothesis that locally increased production of ANG II may contribute to the process of pulmonary vascular remodelling.
Copyright 2000 John Wiley & Sons, Ltd.
Similar articles
-
Angiotensin converting enzyme expression in primary pulmonary hypertension.Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1087-91. doi: 10.1164/ajrccm.154.4.8887612. Am J Respir Crit Care Med. 1996. PMID: 8887612
-
Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.N Engl J Med. 1995 Jul 27;333(4):214-21. doi: 10.1056/NEJM199507273330403. N Engl J Med. 1995. PMID: 7540722
-
Developmental regulation of angiotensin converting enzyme and angiotensin type 1 receptor in the rat pulmonary circulation.Am J Respir Cell Mol Biol. 1996 Jun;14(6):526-37. doi: 10.1165/ajrcmb.14.6.8652181. Am J Respir Cell Mol Biol. 1996. PMID: 8652181
-
Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review).Int J Mol Med. 2002 Mar;9(3):317-25. Int J Mol Med. 2002. Retraction in: Int J Mol Med. 2002 Nov;10(5):665. doi: 10.3892/ijmm.10.5.665 PMID: 11836639 Retracted. Review.
-
Angiotensin-converting enzyme and vascular remodeling.Circ Res. 2007 Aug 31;101(5):441-54. doi: 10.1161/CIRCRESAHA.107.148338. Circ Res. 2007. PMID: 17761934 Review.
Cited by
-
Polydatin attenuates hypoxic pulmonary hypertension and reverses remodeling through protein kinase C mechanisms.Int J Mol Sci. 2012;13(6):7776-7787. doi: 10.3390/ijms13067776. Epub 2012 Jun 21. Int J Mol Sci. 2012. PMID: 22837726 Free PMC article.
-
Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.BMC Cardiovasc Disord. 2016 Oct 10;16(1):192. doi: 10.1186/s12872-016-0366-4. BMC Cardiovasc Disord. 2016. PMID: 27724864 Free PMC article.
-
Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.Toxicol Appl Pharmacol. 2010 May 15;245(1):100-7. doi: 10.1016/j.taap.2010.02.009. Epub 2010 Feb 21. Toxicol Appl Pharmacol. 2010. PMID: 20178811 Free PMC article.
-
Pulmonary Circulation Under Pressure: Pathophysiological and Therapeutic Implications of BK Channel.Cardiovasc Drugs Ther. 2023 Aug 25. doi: 10.1007/s10557-023-07503-7. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37624526 Review.
-
Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.Circulation. 2015 Jun 9;131(23):2079-91. doi: 10.1161/CIRCULATIONAHA.114.006980. Circulation. 2015. PMID: 26056345 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous